A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
WithdrawnOBSERVATIONAL
0
Timeline
Start Date
September 1, 2021
Primary Completion Date
June 30, 2023
Study Completion Date
March 1, 2024
Conditions
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
NCT03804125 - A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery | Biotech Hunter | Biotech Hunter